Dr Shaun Sabico was presented with the ESCEO-IOF Pierre Meunier Young Scientist Award at a special ceremony held on April 6 at the World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Disease (WCO-IOF-ESCEO '19 Paris).
The joint European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis & Musculoskeletal Diseases (ESCEO) and International Osteoporosis Foundation (IOF) award recognizes a young investigator who has demonstrated outstanding scientific merit early in his or her career, prior to reaching a prominent academic position, and who is expected to be a future thought-leader in the musculoskeletal field.
Following the award presentation in Paris, ESCEO President Jean-Yves Reginster stated:
"Low levels of vitamin D are a major problem worldwide and very prevalent across the Middle East, where studies have identified high levels of deficiency in the population. Dr Sabico's commitment and achievements in advancing research and education in this important area of musculoskeletal health are exemplary. He is a highly deserving winner of this year's ESCEO-IOF Pierre Meunier Young Scientist Award."
Dr Sabico completed medical training at the University of Santo Tomas, Philippines and obtained a PhD in medical sciences in 2018 at Warwick Medical School, Warwick University, UK under the mentorship of Prof. Philip McTernan and Prof. Nasser Al-Daghri. Under Prof. Al-Daghri's guidance, Dr Sabico has been instrumental in the spread of vitamin D awareness in Saudi Arabia and the Middle East region through clinical, epidemiologic, genetic and proteomic studies, and has worked with key experts to develop local and regional guidelines for vitamin D and osteoporosis. He is currently the deputy director and incoming assistant professor at the Chair for Biomarkers of Chronic Diseases in King Saud University, Saudi Arabia. His research interests include chronic diseases, vitamin D, probiotics and bone markers. He is author of more than a hundred scientific publications in these fields.
World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO Paris 2019):
Held jointly by IOF and ESCEO, the Congress took place in Paris, France from April 4-7, 2019. WCO-IOF-ESCEO is the world's largest annual forum for the presentation of clinical research and new advances in the prevention and management of bone, muscle and joint disorders, including sarcopenia and frailty. For more information and to view congress abstracts visit
The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers as well as more than 240 patient, medical and research societies in 99 locations, work together to make fracture prevention and healthy mobility a worldwide heath care priority. http://www.
The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception. http://www.